{
    "organizations": [],
    "uuid": "62ab34b69e1a81def39b75507463732518e058b0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-g1-therapeutics-qtrly-net-loss-per/brief-g1-therapeutics-qtrly-net-loss-per-share-0-60-idUSASB0C6QA",
    "ord_in_thread": 0,
    "title": "BRIEF-G1 Therapeutics Qtrly Net Loss Per Share $0.60",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - G1 Therapeutics Inc:\n* G1 THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT OPERATIONAL HIGHLIGHTS\n* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS $0.60\n* Q1 EARNINGS PER SHARE VIEW $-0.60 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T05:40:00.000+02:00",
    "crawled": "2018-02-22T18:19:44.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "g1",
        "therapeutic",
        "inc",
        "g1",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "recent",
        "operational",
        "highlight",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "attributable",
        "common",
        "stockholder",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}